Losartan Potassium Tablets Recalled Due to Impurity Presence
Golden State Medical Supply is recalling Losartan Potassium Tablets because FDA labs found an impurity above acceptable levels.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe rating under the rubric, particularly given the presence of a nitrosamine impurity.
Plain-English summary
Golden State Medical Supply Inc. is recalling 8,767 bottles of Losartan Potassium Tablets USP 100 mg (NDC 60429-318-10). The recall involves 1,000-count HDPE bottles distributed to accounts in Illinois, Michigan, Minnesota, Pennsylvania, Tennessee, and Texas, including two U.S. government and one Veterans Affairs account.
The recall was initiated due to Current Good Manufacturing Practice (CGMP) deviations. FDA laboratory testing confirmed the presence of the impurity N-Methylnitrosobutyric acid (NMBA) in the finished product at levels above the interim acceptable daily intake limit.
Patients and healthcare providers should stop using the affected lots and contact their healthcare provider for alternative treatment options. The specific lot codes and expiration dates are listed in the official recall notice.
The recalled product
- Product
- Losartan Potassium Tablets USP 100 mg 1000 count bottle NDC 60429-318-10 Rx only GSMS Incorporated
- Manufacturer
- Golden State Medical Supply Inc.
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 8,767
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (12)
- GS014054 exp 06/2019
- GS016338 exp 12/2019
- GS016341 exp 01/2020
- GS016342 exp 01/2020
- GS016343 exp 01/2020
- GS016344 exp 01/2020
- GS016345 exp 01/2020
- GS016539 exp 01/2020
- GS016969 exp 01/2020
- GS016973 exp 01/2020
- GS017337 exp 01/2020
- GS018524 exp 02/2020
Distribution
Part of a larger recall action
This product is one of 5 recalled by Golden State Medical Supply Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Golden State Medical Supply Inc.
See all →- ModerateGolden State Medical Supply Recalls Carbamazepine Tablets Due to CGMP Deviations
FDA (Drugs) · 2026-08-26
- ModerateNiacin extended-release tablets failed dissolution testing at 24 hours
FDA (Drugs) · 2026-06-17
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighBaclofen tablet bottles recalled over the presence of foreign tablets
FDA (Drugs) · 2025-12-24
Same hazard · impurity
See all →- ModerateHikma Recalls Ramipril Capsules Due to Process Impurity
FDA (Drugs) · 2026-09-02
- ModerateMedline Remedy Specialized Silicone Cream Recalled for Elevated Formaldehyde Levels
FDA (Drugs) · 2026-07-15
- SevereCinacalcet Hydrochloride Tablets Recalled for Elevated Impurity Levels
FDA (Drugs) · 2026-07-08
- HighDuloxetine 30mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17
- HighDuloxetine 60mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17